Cite Filings / ALLO / 0001564590-19-006991
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-K

Annual Report

Allogene Therapeutics, Inc. · Filed 2019-03-08 · Acc 0001564590-19-006991

Documents 1

  • 10-K Annual Report , allo-10k_20181231.htm

Around this filing

  • 2020-02-27 10-K Annual Report
  • 2019-03-15 4 Chief Financial Officer acquired 49,400 shares (grant or award)
  • 2019-03-15 4 Director acquired 115,333 shares (grant or award)
  • 2019-03-15 4 President and CEO acquired 173,000 shares (grant or award)
  • 2019-03-08 10-K Annual Report
  • 2019-03-08 S-8 Securities Offered to Employees in Benefit Plans
  • 2019-03-08 8-K Results of operations

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading allo-10k_20181231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…